Pharmacokinetics of sarafloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications

Journal of Veterinary Pharmacology and Therapeutics

Volumn 24, Issue 5, 2001, Pages 303-308

  Ding, H Z ^a   Zeng, Z L ^a   Fung, K F ^a   Chen, Z L ^a   Qiao, G L ^b,c  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ENROFLOXACIN; NORDIFLOXACIN;

ANALYTIC METHOD; ANIMAL DISEASE; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; CHICKEN; CONTROLLED STUDY; DISTRIBUTION VOLUME; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; MEAN RESIDENCE TIME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SWINE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHICKENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; FLUOROQUINOLONES; HALF-LIFE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; SPECIES SPECIFICITY; SWINE; TISSUE DISTRIBUTION;

ANIMALIA; BACTERIA (MICROORGANISMS); GALLUS GALLUS; SUS SCROFA;

EID: 0034780952     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2001.00348.x     Document Type: Article

References (24)

1. Pharmacokinetic properties of norfloxacin in pigs
2. Pharmacokinetics of ciprofloxacin following intravenous and oral administration in broilers
3. Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro
4. Fluoroquinolones in animal health
5. Antimicrobial and pharmacokinetic studies of fluoroquinolones in chickens
6. In vitro activities of A-56619 (difloxacin) and A-56620, two aryl fluoroquinolones
7. In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620
8. Bioavailability and pharmacokinetics of ciprofloxacin in pigs
9. In vivo evaluation of A-56619 (difloxacin) and A-56620: New aryl-fluoroquinolones
10. Distribution and elimination of sarafloxacin hydrochloride from tissues of juvenile channel catfish (Ictalurus Punctatus)
11. Pharmacokinetics of enrofloxacin and its metabolite in broilers
12. Pharmacokinetics of enrofloxacin and danofloxacin in broilers
13. Pharmacokinetic studies of ofloxacin in healthy and diseased chickens infected with Mycoplasma gallinarum and E. coli
14. Multiple dose pharmacokinetic and depletion studies of sarafloxacin in Atlantic salmon, Salmo salar L.
15. Single dose kinetic study of sarafloxacin after intravenous and oral administration of different formulations to Atlantic salmon (Salmo salar) held in sea water at 8.5°C
16. Single dose kinetic study of sarafloxacin after intravascular and oral administration to cannulated Atlantic Salmon (Salmo salar) held in sea water at 12°C
17. Assay of ciprofloxacin and norfloxacin in serum and urine by high-performance liquid chromatography
18. Plasma pharmacokinetics of parenterally administered danofloxacin and enrofloxacin in pigs
19. Pharmacodynamic and pharmacokinetic inter-relationships of antibacterial drugs
20. In vitro activity of A-56619 and A-56620, two new aryl-fluoroquinolone antimicrobial agents
21. Pharmacodynamics of sarafloxacin against experimentally induced Streptococcosis suum and Colobacillosis in pigs
22. Effects of experimentally induced Escherichia coli infection on the pharmacokinetics of enrofloxacin in pigs